Short-term DTI predictors of cognitive dysfunction in mild traumatic brain injury

Laura Miles1, Robert I Grossman, Glyn Johnson

  • 1Department of Radiology, New York University School of Medicine, New York, NY 10016, USA.

Brain Injury
|February 2, 2008
PubMed
Abstract

Insights

Diffusion tensor imaging (DTI) metrics show potential for predicting cognitive function after mild traumatic brain injury (MTBI). Baseline DTI measures like mean diffusivity and fractional anisotropy may offer early insights into recovery.

Area of Science:

  • Neuroimaging
  • Neurology
  • Radiology

Background:

  • Mild traumatic brain injury (MTBI) can lead to persistent cognitive deficits.
  • Current methods for predicting long-term outcomes in MTBI patients are limited.
  • Diffusion tensor imaging (DTI) offers a non-invasive way to assess white matter integrity.

Purpose of the Study:

  • To investigate if baseline diffusion tensor imaging (DTI) metrics can predict cognitive functioning at 6 months post-mild traumatic brain injury (MTBI).
  • To establish DTI as a potential tool for early prognostication in MTBI patients.

Main Methods:

  • Seventeen MTBI patients and 29 healthy controls underwent MRI with DTI within 10 days of injury.
  • Mean diffusivity (MD) and fractional anisotropy (FA) were quantified in specific white matter regions.
  • Neuropsychological testing was performed at baseline and 6-month follow-up, with regression analysis used to assess associations.

Main Results:

  • MTBI patients exhibited significantly higher mean diffusivity (MD) and lower fractional anisotropy (FA) compared to controls.
  • A trend was observed between baseline MD and response speed (p=0.087).
  • A significant positive correlation was found between baseline FA and Prioritization form B performance (r=0.72, p=0.003).

Conclusions:

  • Baseline DTI metrics, specifically MD and FA, show promise as non-invasive predictive markers for cognitive function in MTBI.
  • These findings suggest DTI could aid in the short-term prognosis of MTBI patients.
  • Further research is warranted to validate DTI's predictive capabilities in larger cohorts.